147 related articles for article (PubMed ID: 38104000)
1. The gut microbiota in adults with cystic fibrosis compared to colorectal cancer.
Caley LR; Wood HM; Bottomley D; Fuentes Balaguer A; Wilkinson L; Dyson J; Young C; White H; Benton S; Brearley M; Quirke P; Peckham DG
J Cyst Fibros; 2024 Mar; 23(2):262-268. PubMed ID: 38104000
[TBL] [Abstract][Full Text] [Related]
2. The altered gut microbiota in adults with cystic fibrosis.
Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
[TBL] [Abstract][Full Text] [Related]
3. Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
Schippa S; Iebba V; Santangelo F; Gagliardi A; De Biase RV; Stamato A; Bertasi S; Lucarelli M; Conte MP; Quattrucci S
PLoS One; 2013; 8(4):e61176. PubMed ID: 23613805
[TBL] [Abstract][Full Text] [Related]
4. The Intestinal Microbiome and Cystic Fibrosis Transmembrane Conductance Regulator Modulators: Emerging Themes in the Management of Gastrointestinal Manifestations of Cystic Fibrosis.
Karb DB; Cummings LC
Curr Gastroenterol Rep; 2021 Aug; 23(10):17. PubMed ID: 34448955
[TBL] [Abstract][Full Text] [Related]
5. Development of the intestinal microbiome in cystic fibrosis in early life.
Price CE; Hampton TH; Valls RA; Barrack KE; O'Toole GA; Madan JC; Coker MO
mSphere; 2023 Aug; 8(4):e0004623. PubMed ID: 37404016
[TBL] [Abstract][Full Text] [Related]
6. Lung and Gut Microbiota Changes Associated with
Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
[TBL] [Abstract][Full Text] [Related]
7. Development of the gut microbiota in early life: The impact of cystic fibrosis and antibiotic treatment.
Kristensen M; Prevaes SMPJ; Kalkman G; Tramper-Stranders GA; Hasrat R; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets B; Keijser B; van der Ent CK; Bogaert D
J Cyst Fibros; 2020 Jul; 19(4):553-561. PubMed ID: 32487494
[TBL] [Abstract][Full Text] [Related]
8. A systematic review of the colorectal microbiome in adult cystic fibrosis patients.
Gilbert B; Kaiko G; Smith S; Wark P
Colorectal Dis; 2023 May; 25(5):843-852. PubMed ID: 36598333
[TBL] [Abstract][Full Text] [Related]
9. Intestinal function and transit associate with gut microbiota dysbiosis in cystic fibrosis.
Marsh R; Gavillet H; Hanson L; Ng C; Mitchell-Whyte M; Major G; Smyth AR; Rivett D; van der Gast C
J Cyst Fibros; 2022 May; 21(3):506-513. PubMed ID: 34895838
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.
Vernocchi P; Del Chierico F; Russo A; Majo F; Rossitto M; Valerio M; Casadei L; La Storia A; De Filippis F; Rizzo C; Manetti C; Paci P; Ercolini D; Marini F; Fiscarelli EV; Dallapiccola B; Lucidi V; Miccheli A; Putignani L
PLoS One; 2018; 13(12):e0208171. PubMed ID: 30521551
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiota in Children With Cystic Fibrosis: A Taxonomic and Functional Dysbiosis.
Coffey MJ; Nielsen S; Wemheuer B; Kaakoush NO; Garg M; Needham B; Pickford R; Jaffe A; Thomas T; Ooi CY
Sci Rep; 2019 Dec; 9(1):18593. PubMed ID: 31819107
[TBL] [Abstract][Full Text] [Related]
12. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
[TBL] [Abstract][Full Text] [Related]
13. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
[TBL] [Abstract][Full Text] [Related]
14. Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated with Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.
Kim M; Vogtmann E; Ahlquist DA; Devens ME; Kisiel JB; Taylor WR; White BA; Hale VL; Sung J; Chia N; Sinha R; Chen J
mBio; 2020 Feb; 11(1):. PubMed ID: 32071266
[TBL] [Abstract][Full Text] [Related]
15. Altered intestinal microbiota associated with colorectal cancer.
Zhang H; Chang Y; Zheng Q; Zhang R; Hu C; Jia W
Front Med; 2019 Aug; 13(4):461-470. PubMed ID: 31250341
[TBL] [Abstract][Full Text] [Related]
16. Impact of CFTR modulation with Ivacaftor on Gut Microbiota and Intestinal Inflammation.
Ooi CY; Syed SA; Rossi L; Garg M; Needham B; Avolio J; Young K; Surette MG; Gonska T
Sci Rep; 2018 Dec; 8(1):17834. PubMed ID: 30546102
[TBL] [Abstract][Full Text] [Related]
17. The gut microbiome, short chain fatty acids, and related metabolites in cystic fibrosis patients with and without colonic adenomas.
Baldwin-Hunter BL; Rozenberg FD; Annavajhala MK; Park H; DiMango EA; Keating CL; Uhlemann AC; Abrams JA
J Cyst Fibros; 2023 Jul; 22(4):738-744. PubMed ID: 36717332
[TBL] [Abstract][Full Text] [Related]
18. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis.
Li L; Krause L; Somerset S
Clin Nutr; 2017 Aug; 36(4):1097-1104. PubMed ID: 27595636
[TBL] [Abstract][Full Text] [Related]
19. Cystic fibrosis mouse model-dependent intestinal structure and gut microbiome.
Bazett M; Honeyman L; Stefanov AN; Pope CE; Hoffman LR; Haston CK
Mamm Genome; 2015 Jun; 26(5-6):222-34. PubMed ID: 25721416
[TBL] [Abstract][Full Text] [Related]
20. Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R; Dos Santos C; Hanson L; Ng C; Major G; Smyth AR; Rivett D; van der Gast C
Microbiol Spectr; 2023 Aug; 11(5):e0117523. PubMed ID: 37607068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]